Multifunctionalized gold nanoparticles with peptides targeted to gastrin-releasing peptide receptor of a tumor cell line

Bioconjugate Chemistry

Volumn 21, Issue 6, 2010, Pages 1070-1078

  Hosta Rigau, Leticia ^a   Olmedo, Ivonne ^b   Arbiol, Jordi ^d   Cruz, Luis J ^a   Kogan, Marcelo J ^b,c   Albericio, Fernando ^a,e  

^a INSTITUTE FOR RESEARCH IN BIOMEDICINE   (Spain)

^b UNIVERSITY OF CHILE   (Chile)

^c Ctr Adv Interdisc Res in Mat   (Chile)

^d INSTITUT DE CIÈNCIA DE MATERIALS DE BARCELONA ICMAB CSIC   (Spain)

^e UNIVERSITY OF BARCELONA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

BOMBESIN DERIVATIVE; GASTRIN RELEASING PEPTIDE; GASTRIN RELEASING PEPTIDE DERIVATIVE; GASTRIN RELEASING PEPTIDE RECEPTOR; GOLD NANOPARTICLE;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL CULTURE; CELL VIABILITY; DRUG CONJUGATION; DRUG RECEPTOR BINDING; HELA CELL; IN VITRO STUDY; NEUROBLASTOMA; PROTEIN EXPRESSION;

EID: 77953642466     PISSN: 10431802     EISSN: 15204812     Source Type: Journal    
DOI: 10.1021/bc1000164     Document Type: Article

References (62)

1. Sokolov, K., Follen, M., Aaron, J., Pavlova, I., Malpica, A., Lotan, R., and Richards-Kortum, R. (2003) Real-time vital optical imaging of precancer using anti-epidermal growth factor receptor antibodies conjugated to gold nanoparticles Cancer Res. 63, 1999-2004
2. Elghanian, R., Storhoff, J. J., Mucic, R. C., Letsinger, R. L., and Mirkin, C. A. (1997) Selective colorimetric detection of polynucleotides based on the distance-dependent optical properties of gold nanoparticles Science 277, 1078-1081
3. Bhattacharya, R., Mukherjee, P., Xiong, Z., Atala, A., Soker, S., and Mukhopadhyay, D. (2004) Gold nanoparticles inhibit VEGF165-induced proliferation of HUVEC cells Nano Lett. 4, 2479-2481
4. Kogan, M. J., Olmedo, I., Hosta, L., Guerrero, A. R., Cruz, L. J., and Albericio, F. (2007) Peptides and metallic nanoparticles for biomedical applications Nanomedicine 2, 287-306
5. Zharov, V. P., Mercer, K. E., Galitovskaya, E. N., and Smeltzer, M. S. (2006) Photothermal nanotherapeutics and nanodiagnostics for selective killing of bacteria targeted with gold nanoparticles Biophys. J. 90, 619-627
6. Zharov, V. P., Galitovskaya, E. N., Johnson, C., and Kelly, T. (2005) Synergistic enhancement of selective nanophotothermolysis with gold nanoclusters: Potential for cancer therapy Lasers Surg. Med. 37, 219-226
7. Tkachenko, A. G., Xie, H., Liu, Y. L., Coleman, D., Ryan, J., Glomm, W. R., Shipton, M. K., Franzen, S., and Feldheim, D. L. (2004) Cellular trajectories of peptide-modified gold particle complexes: Comparison of nuclear localization signals and peptide transduction domains Bioconjugate Chem. 15, 482-490
8. Thurn, K. T., Brown, E. M. B., Wu, A., Vogt, S., Lai, B., Maser, J., Paunesku, T., and Woloschak, G. E. (2007) Nanoparticles for applications in cellular Imaging Nanoscale Res. Lett. 2, 430-441
9. Tkachenko, A. G., Xie, H., Coleman, D., Glomm, W., Ryan, J., Anderson, M. F., Franzen, S., and Feldheim, D. L. (2003) Multifunctional gold nanoparticle-peptide complexes for nuclear targeting J. Am. Chem. Soc. 125, 4700-4701
10. Efremov, R. G., Chugunov, A. O., Pyrkov, T. V., Priestle, J. P., Arseniev, A. S., and Jacoby, E. (2007) Molecular lipophilicity in protein modeling and drug design Curr. Med. Chem. 14, 393-415
11. Pissuwan, D., Valenzuela, S. M., Miller, C. M., and Cortie, M. B. (2007) A golden bullet- Selective targeting of toxoplasma gondii tachyzoites using anti body-functionalized gold nanorods Nano Lett. 7, 3808-3812
12. Souza, G. R., Christianson, D. R., Staquicini, F. I., Ozawa, M. G., Snyder, E. Y., Sidman, R. L., Miller, J. H., Arap, W., and Pasqualini, R. (2006) Networks of gold nanoparticles and bacteriophage as biological sensors and cell-targeting agents Proc. Natl. Acad. Sci. U.S.A. 103, 1215-1220
13. Qian, X. M., Peng, X. H., Ansari, D. O., Yin-Goen, Q., Chen, G. Z., Shin, D. M., Yang, L., Young, A. N., Wang, M. D., and Nie, S. M. (2008) In vivo tumor targeting and spectroscopic detection with surface-enhanced Raman nanoparticle tags Nat. Biotechnol. 26, 83-90
14. Scopinaro, F., De Vincentis, G., and Varvarigou, A. D. (2005) Use of radiolabeled bombesin in humans J. Clin. Oncol. 23, 3170-3171
15. Bartholdi, M. F., Wu, J. M., Pu, H. F., Troncoso, P., Eden, P. A., and Feldman, R. I. (1998) In situ hybridization for gastrin-releasing peptide receptor (GRP receptor) expression in prostatic carcinoma Int. J. Cancer 79, 82-90
16. Markwalder, R. and Reubi, J. C. (1999) Gastrin-releasing peptide receptors in the human prostate: Relation to neoplastic transformation Cancer Res. 59, 1152-1159
17. Chanda, N., Shukla, R., Katti, K. V., and Kannan, R. (2009) Gastrin releasing protein receptor specific gold nanorods: breast and prostate tumor avid nanovectors for molecular imaging Nano Lett. 9, 1798-1805
18. Schwartsmann, G., DiLeone, L. P., Horowitz, M., Schunemann, D., Cancella, A., Pereira, A. S., Richter, M., Souza, F., da Rocha, A. B., Souza, F. H., Pohlmann, P., and de Nucci, G. (2006) A phase I trial of the bombesin/gastrin-releasing peptide (BN/GRP) antagonist RC3095 in patients with advanced solid malignancies Invest. New Drugs 24, 403-412
19. Varvarigou, A., Bouziotis, P., Zikos, C., Scopinaro, F., and De Vincentis, G. (2004) Cancer Biother. Radiopharm. 19, 219-229
20. Cornelio, D. B., Meurer, L., Roesler, R., and Schwartsmann, G. (2007) Gastrin-releasing peptide receptor expression in cervical cancer Oncology 73, 340-345
21. Dasgupta, P., Sun, J. Z., Wang, S., Fusaro, G., Betts, V., Padmanabhan, J., Sebti, S. M., and Chellappan, S. P. (2004) Disruption of the Rb-Raf-1 interaction inhibits tumor growth and angiogenesis Mol. Cell. Biol. 24, 9527-9541
22. Kim, J. H., Kim, K.-W., Kim, M. H., and Yu, Y. S. (2009) Intravenously administered gold nanoparticles pass through the blood-retinal barrier depending on the particle size, and induce no retinal toxicity Nanotechnology 20, 505101-9
23. De Jong, W. H., Hagens, W. I., Krystek, P., Burger, M. C., Sips, A. J., and Geertsma, R. E. ((2008) Particle size-dependent organ distribution of gold nanoparticles after intravenous administration.) -Biomaterials 29 1912-9
24. Sonavane, G., Tomoda, K., and Makino, K. (2008) Biodistribution of colloidal gold nanoparticles after intravenous administration: effect of particle size Colloids Surf., B 66, 274-80
25. Chithrani, D. B., Ghazani, A. A., and Chan, W. C. W. (2006) Determining the size and shape dependence of gold nanoparticle uptake into mammalian cells Nano Lett. 6 (4) 662-668
26. Connor, E. E., Mwamuka, J., Gole, A., Murphy, C., and Wyatt, M. D. (2005) Gold nanoparticles are taken up by human cells but do not cause acute cytotoxicity Small 1 (3) 325-327
27. Kahn, J., Oillai, B., Das, T. K., Singh, Y., and Maiti, S. (2007) Molecular effects of uptake of gold nanoparticles in HeLa cell ChemBiochem 8, 1237-1240
28. Bar-Ilan, O., Albrecht, R. M., Fako, V. E., and Furgeson, F. (2009) Toxicity assessments of multisized gold and silver nanoparticles in zebrafish embryos Small 5 (16) 1897-1910
29. H-Pan, Y., Neuss, S., Leifert, A., Fischler, M., Wen, F., and Simon, U. (2007) Size-dependent cytotoxicity of gold nanoparticles Small 3 (11) 1941-1949
30. Tsoli, M., Kuhn, H., Brandau, W., Esche, H., and Schmid, G. (2005) Cellular uptake and toxicity of Au55 clusters Small 1 (8-9) 841-844
31. Nagy, A., Armatis, P., Cai, R. Z., Szepeshazi, K., Halmos, G., and Schally, A. V. (1997) Design, synthesis, and in vitro evaluation of cytotoxic analogs of bombesin-like peptides containing doxorubicin or its intensely potent derivative, 2-pyrrolinodoxorubicin Proc. Natl. Acad. Sci. U.S.A. 94, 652-656
32. Reubi, J. C. (1995) Neuropeptide receptors in health and disease-the molecular-basis for in-vivo imaging J. Nucl. Med. 36, 1825-1835
33. Moody, T. W., Mahmoud, S., Staley, J., Naldini, L., Cirillo, D., South, V., Felder, S., and Kris, R. (1989) Human glioblastoma cell-lines have neuropeptide receptors for bombesin gastring-releasing peptide J. Mol. Neurosci. 1, 235-242
34. Moody, T. W., Carney, D. N., Cuttitta, F., Quattrocchi, K., and Minna, J. D. (1985) High-affinity receptors for bombesin GRP-like peptides on human small cell lung-cancer Life Sci. 37, 105-113
35. Qin, Y. F., Ertl, T., Cai, R. Z., Halmos, G., and Schally, A. V. (1994) Inhibitory effect of bombesin receptor antagonistic RC-3095 on the growth of human pancreatic-cancer cells in-vivo and in-vitro Cancer Res. 54, 1035-1041
36. Yano, T., Pinski, J., Groot, K., and Schally, A. V. (1992) Stimulation by bombesin and inhibition by bombesin gastrin-releasing peptide antagonist RC-3095 of growth of human breast-cancer cell-lines Cancer Res. 52, 4545-4547
37. Preston, S. R., Woodhouse, L. F., Jonesblackett, S., Miller, G. V., and Primrose, J. N. (1995) High-affinity binding-sites for gastrin-releasing peptide on human colorectal-cancer tissue but not uninvolved mucosa Br. J. Cancer 71, 1087-1089
38. Shriver, S. P., Bourdeau, H. A., Gubish, C. T., Tirpak, D. L., Davis, A. L. G., Luketich, J. D., and Siegfried, J. M. (2000) Sex-specific expression of gastrin-releasing peptide receptor: Relationship to smoking history and risk of lung cancer J. Natl. Cancer Inst. 92, 24-33
39. Lin, K. S., Luu, A., Baidoo, K. E., Hashemzadeh-Gargari, H., Chen, M. K., Pili, R., Pomper, M., Carducci, M., and Wagner, H. N. (2004) A new high affinity technetium analogue of bombesin containing DTPA as a pharmacokinetic modifier Bioconjugate Chem. 15, 1416-1423
40. Schally, A. V. and Nagy, A. (1999) Cancer chemotherapy based on targeting of cytotoxic peptide conjugates to their receptors on tumors Eur. J. End. 141, 1-14
41. Szereday, Z., Schally, A. V., Nagy, A., Plonowski, A., Bajo, A. M., Halmos, G., Szepeshazi, K., and Groot, K. (2002) Effective treatment of experimental U-87MG human glioblastoma in nude mice with a targeted cytotoxic bombesin analogue, AN-215 Br. J. Cancer 86, 1322-1327
42. Zhang, H. W., Chen, J. H., Waldherr, C., Hinni, K., Waser, B., Reubi, J. C., and Maecke, H. R. (2004) Synthesis and evaluation of bombesin derivatives on the basis of pan-bombesin peptides labeled with indium-111, lutetium-177, and yttrium-90 for targeting bombesin receptor-expressing tumors Cancer Res. 64, 6707-6715
43. Wang, S., Ghosh, R. N., and Chellappan, S. P. (1998) Raf-1 physically interacts with Rb and regulates its function: a link between mitogenic signaling and cell cycle regulation Mol. Cel. Biol. 18, 7487-7498
44. Moody, T. W., Crawley, J. N., and Jensen, R. T. (1982) Pharmacology and neurochemistry of bombesin-like peptides Peptides 3, 559-563
45. Hoehne, A., Mu, L., Honer, M., Schubiger, P. A., Ametamey, S. M., Graham, K., Stellfeld, T., Borkowski, S., Berndorff, D., Klar, U., Voigtmann, U., Cyr, J. E., Friebe, M., Dinkelborg, L., and Srinivasan, A. (2008) Synthesis, F-18-labeling, and in vitro and in vivo studies of bombesin peptides modified with silicon-based building blocks Bioconjugate Chem. 19, 1871-1879
46. Hoffman, T. J., Quinn, T. P., and Volkert, W. A. (2001) Radiometallated receptor avid peptide conjugates for specific targeting of cancer cells J. Nucl. Med. 28, 527-539
47. Hoffman, T. J., Gali, H., Smith, C. J., Sieckman, G. L., Hayes, D. L., Owen, N. K., and Volkert, W. A. (2003) Novel series of In-111-labeled bombesin analogs as potential radiopharmaceuticals for specific targeting of gastrin-releasing peptide receptors expressed on human prostate cancer cells J. Nucl. Med. 44, 823-831
48. Abd-Elgaliel, W. R., Gallazzi, F., Garrison, J. C., Rold, T. L., Sieckman, G. L., Figueroa, S. D., Hoffman, T. J., and Lever, S. Z. (2008) Design, synthesis, and biological evaluation of an antagonist-bombesin analogue as targeting vector Bioconjugate Chem. 19, 2040-2048
49. Hoffman, T. J., Simpson, S. D., Smith, C. J., Simmons, J., Siekman, G. L., Higginbotham, C., Eshima, D., Volkert, W., and Thornback, J. R. (1999) Accumulation and retention of Tc-99m RP591 by GRP receptor expressing tumours in SCID mice Eur. J. Nucl. Med. 26 PS416
50. Hoffman, T. J., Smith, C. J., Simpson, S. D., Sieckman, G. L., Higginbotham, C., Jimenez, H., Eshima, D., Thornback, J. R., and Volkert, W. A. (2000) Optimizing pharmacokinetics of Tc-99m-GRP receptor targeting peptides using multi-amino acid linking groups J. Nucl. Med. 41, 1013
51. Bauer, G., Hassmann, J., Walter, H., Haglmuller, J., Mayer, C., and Schalkhammer, T. (2003) Resonant nanocluster technology-from optical coding and high quality security features to biochips Nanotechnology 14, 1289-1311
52. Hogemann, D., Ntziachristos, V., Josephson, L., and Weissleder, R. (2002) High throughput magnetic resonance imaging for evaluating targeted nanoparticle probes Bioconjugate Chem. 13, 116-121
53. Liu, J. Q., Zhang, Q., Remsen, E. E., and Wooley, K. L. (2001) Nanostructured materials designed for cell binding and transduction Biomacromolecules 2, 362-368
54. Marinakos, S. M., Anderson, M. F., Ryan, J. A., Martin, L. D., and Feldheim, D. L. (2001) Encapsulation, permeability, and cellular uptake characteristics of hollow nanometer-sized conductive polymer capsules J. Phys. Chem. B 105, 8872-8876
55. West, J. L. and Halas, N. J. (2000) Applications of nanotechnology to biotechnology-Commentary Curr. Opin. Biotechnol. 11, 215-217
56. McLean, J. A., Stumpo, K. A., and Russell, D. H. (2005) Size-selected (2′10 nm) gold nanoparticles for matrix assisted laser desorption ionization of peptides J. Am. Chem. Soc. 127, 5304-5305
57. Haiss, W., Thanh, N. T. K., Aveyard, J., and Fernig, D. G. (2007) Determination of size and concentration of gold nanoparticles from UV-Vis spectra Anal. Chem. 79, 4215-4221
58. Hosta, L., Pla-Roca, M., Arbiol, J., Lopez-Iglesias, C., Samitier, J., Cruz, L. J., Kogan, M. J., and Albericio, F. (2009) Conjugation of Kahalalide F with gold nanoparticles to enhance in vitro antitumoral activity Bioconjugate Chem. 20, 138-146
59. Davis, R. K. and Chellappan, S. (2008) Disrupting the Rb- Raf -1 interaction: a potential therapeutic target for cancer Drug News Persp. 21, 331-335
60. Ciuffreda, L., McCubrey, J. A., and Milella, M. (2009) Signaling intermediates (PI3K/PTEN/AKT/mTOR and RAF /MEK/ERK pathways) as therapeutic targets for anti-cancer and anti- angiogenesis treatments Curr. Signal Transduction Ther. 4, 130-143
61. Kaiser, E., Colescott, R L., Bossinger, C. D., and Cook, P. I. (1970) Color test for detection of free terminal amino groups in the solid-phase synthesis of peptides Anal. Biochem. 34, 595-598
62. Olmedo, I., Araya, E., Sanz, F., Medina, E., Arbiol, J., Toledo, P., Alvarez-Lueje, A., Giralt, E., and Kogan, M. J. (2008) How changes in the sequence of the peptide CLPFFD-NH2 can modify the conjugation and stability of gold nanoparticles and their affinity for β-amyloid fibrils Bioconjugate Chem. 19, 1154-63